| Year |
Citation |
Score |
| 2019 |
Espinosa DA, Beatty PR, Reiner GL, Sivick KE, Hix Glickman L, Dubensky TW, Harris E. Cyclic Dinucleotide-Adjuvanted Dengue Virus Nonstructural 1 Protein Induces Protective Antibody and T Cell Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 30642979 DOI: 10.4049/Jimmunol.1801323 |
0.546 |
|
| 2018 |
Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, Hudson TE, Vu UT, Francica BJ, Banda T, Katibah GE, Kanne DB, Leong JJ, Metchette K, Bruml JR, et al. Magnitude of Therapeutic STING Activation Determines CD8 T Cell-Mediated Anti-tumor Immunity. Cell Reports. 25: 3074-3085.e5. PMID 30540940 DOI: 10.1016/J.Celrep.2018.11.047 |
0.355 |
|
| 2018 |
Van Dis E, Sogi KM, Rae CS, Sivick KE, Surh NH, Leong ML, Kanne DB, Metchette K, Leong JJ, Bruml JR, Chen V, Heydari K, Cadieux N, Evans T, McWhirter SM, et al. STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection. Cell Reports. 23: 1435-1447. PMID 29719256 DOI: 10.1016/J.Celrep.2018.04.003 |
0.573 |
|
| 2017 |
Sivick KE, Surh NH, Desbien AL, Grewal EP, Katibah GE, McWhirter SM, Dubensky TW. Comment on "The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele". Journal of Immunology (Baltimore, Md. : 1950). 198: 4183-4185. PMID 28533276 DOI: 10.4049/Jimmunol.1700294 |
0.412 |
|
| 2014 |
Sivick KE, Arpaia N, Reiner GL, Lee BL, Russell BR, Barton GM. Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies. Cell Host & Microbe. 15: 203-13. PMID 24528866 DOI: 10.1016/J.Chom.2014.01.013 |
0.334 |
|
| 2014 |
Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Lemmens E, Leong JJ, Metchette K, Dubensky TW, Gajewski T. Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-O10 |
0.344 |
|
| 2011 |
Arpaia N, Godec J, Lau L, Sivick KE, McLaughlin LM, Jones MB, Dracheva T, Peterson SN, Monack DM, Barton GM. TLR signaling is required for Salmonella typhimurium virulence. Cell. 144: 675-88. PMID 21376231 DOI: 10.1016/J.Cell.2011.01.031 |
0.333 |
|
| 2010 |
Sivick KE, Schaller MA, Smith SN, Mobley HL. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. Journal of Immunology (Baltimore, Md. : 1950). 184: 2065-75. PMID 20083670 DOI: 10.4049/Jimmunol.0902386 |
0.567 |
|
| 2010 |
Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infection and Immunity. 78: 568-85. PMID 19917708 DOI: 10.1128/Iai.01000-09 |
0.677 |
|
| 2009 |
Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HL. Mucosal immunization with iron receptor antigens protects against urinary tract infection. Plos Pathogens. 5: e1000586. PMID 19806177 DOI: 10.1371/Journal.Ppat.1000586 |
0.509 |
|
| 2009 |
Sivick KE, Mobley HL. An "omics" approach to uropathogenic Escherichia coli vaccinology. Trends in Microbiology. 17: 431-2. PMID 19758805 DOI: 10.1016/J.Tim.2009.07.003 |
0.672 |
|
| 2008 |
Crimmins GT, Herskovits AA, Rehder K, Sivick KE, Lauer P, Dubensky TW, Portnoy DA. Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proceedings of the National Academy of Sciences of the United States of America. 105: 10191-6. PMID 18632558 DOI: 10.1073/Pnas.0804170105 |
0.414 |
|
| 2006 |
Maroncle NM, Sivick KE, Brady R, Stokes FE, Mobley HL. Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli. Infection and Immunity. 74: 6124-34. PMID 16954394 DOI: 10.1128/Iai.01086-06 |
0.484 |
|
| Show low-probability matches. |